Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review

被引:8
作者
Aldinc, Emre [1 ]
Campbell, Courtney [2 ]
Gustafsson, Finn [3 ]
Beveridge, Abigail [4 ]
Macey, Richard [4 ]
Marr, Laura [4 ]
Summers, Catherine [1 ]
Zhang, Dafang [5 ]
机构
[1] Alnylam Pharmaceut, Cambridge, MA 02115 USA
[2] Baylor Scott & White Heart & Vasc Hosp, Dallas, TX USA
[3] Univ Copenhagen, Rigshopsitalet, Copenhagen, Denmark
[4] Adelphi Values PROVETM, Bollington, England
[5] Brigham & Womens Hosp, Boston, MA USA
关键词
CARPAL-TUNNEL-SYNDROME; POLYNEUROPATHY TTR-FAP; CARDIAC AMYLOIDOSIS; LIGAMENTUM-FLAVUM; COMMON-CAUSE; CLINICAL CHARACTERISTICS; HIGH PREVALENCE; HEART-FAILURE; DEPOSITION; MUTATIONS;
D O I
10.1186/s12891-023-06853-5
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundHereditary and wild-type transthyretin-mediated (ATTRv and ATTRwt) amyloidoses result from the misfolding of transthyretin and aggregation of amyloid plaques in multiple organ systems. Diagnosis of ATTR amyloidosis is often delayed due to its heterogenous and non-specific presentation. This review investigates the association of musculoskeletal (MSK) manifestations with ATTR amyloidosis and the delay from the onset of these manifestations to the diagnosis of ATTR amyloidosis.MethodsThis systematic review utilized Medline and EMBASE databases. Search criteria were outlined using a pre-specified patient, intervention, comparator, outcome, time, study (PICOTS) criteria and included: amyloidosis, ATTR, and MSK manifestations. Publication quality was assessed utilizing Joanna Briggs Institute (JBI) critical appraisal checklists.The search initially identified 7,139 publications, 164 of which were included. PICOTS criteria led to the inclusion of epidemiology, clinical burden and practice, pathophysiology, and temporality of MSK manifestations associated with ATTR amyloidosis. 163 publications reported on ATTR amyloidosis and MSK manifestations, and 13 publications reported on the delay in ATTR amyloidosis diagnosis following the onset of MSK manifestations.MethodsThis systematic review utilized Medline and EMBASE databases. Search criteria were outlined using a pre-specified patient, intervention, comparator, outcome, time, study (PICOTS) criteria and included: amyloidosis, ATTR, and MSK manifestations. Publication quality was assessed utilizing Joanna Briggs Institute (JBI) critical appraisal checklists.The search initially identified 7,139 publications, 164 of which were included. PICOTS criteria led to the inclusion of epidemiology, clinical burden and practice, pathophysiology, and temporality of MSK manifestations associated with ATTR amyloidosis. 163 publications reported on ATTR amyloidosis and MSK manifestations, and 13 publications reported on the delay in ATTR amyloidosis diagnosis following the onset of MSK manifestations.ResultsThe MSK manifestation most frequently associated with ATTR amyloidosis was carpal tunnel syndrome (CTS); spinal stenosis (SS) and osteoarthritis (OA), among others, were also identified. The exact prevalence of different MSK manifestations in patients with ATTR amyloidosis remains unclear, as a broad range of prevalence estimates were reported. Moreover, the reported prevalence of MSK manifestations showed no clear trend or distinction in association between ATTRv and ATTRwt amyloidosis.MSK manifestations precede the diagnosis of ATTR amyloidosis by years, and there was substantial variation in the reported delay to ATTR amyloidosis diagnosis. Reports do suggest a longer diagnostic delay in patients with ATTRv amyloidosis, with 2 to 12 years delay in ATTRv versus 1.3 to 1.9 years delay in ATTRwt amyloidosis.ResultsThe MSK manifestation most frequently associated with ATTR amyloidosis was carpal tunnel syndrome (CTS); spinal stenosis (SS) and osteoarthritis (OA), among others, were also identified. The exact prevalence of different MSK manifestations in patients with ATTR amyloidosis remains unclear, as a broad range of prevalence estimates were reported. Moreover, the reported prevalence of MSK manifestations showed no clear trend or distinction in association between ATTRv and ATTRwt amyloidosis.MSK manifestations precede the diagnosis of ATTR amyloidosis by years, and there was substantial variation in the reported delay to ATTR amyloidosis diagnosis. Reports do suggest a longer diagnostic delay in patients with ATTRv amyloidosis, with 2 to 12 years delay in ATTRv versus 1.3 to 1.9 years delay in ATTRwt amyloidosis.ConclusionThese findings suggest that orthopedic surgeons may play a role in the early diagnosis of and treatment referrals for ATTR amyloidosis. Detection of MSK manifestations may enable earlier diagnosis and administration of effective treatments before disease progression occurs.
引用
收藏
页数:37
相关论文
共 185 条
  • [1] Abboud A, 2020, J AM COLL CARDIOL, V75, P820
  • [2] Distribution of amyloidosis subtypes based on tissue biopsy site - Consecutive analysis of 729 patients at a single amyloidosis center in Japan
    Abe, Ryuta
    Katoh, Nagaaki
    Takahashi, Yusuke
    Takasone, Ken
    Yoshinaga, Tsuneaki
    Yazaki, Masahide
    Kametani, Fuyuki
    Sekijima, Yoshiki
    [J]. PATHOLOGY INTERNATIONAL, 2021, 71 (01) : 70 - 79
  • [3] Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
    Adams, D.
    Gonzalez-Duarte, A.
    O'Riordan, W. D.
    Yang, C. -C.
    Ueda, M.
    Kristen, A. V.
    Tournev, I.
    Schmidt, H. H.
    Coelho, T.
    Berk, J. L.
    Lin, K. -P.
    Vita, G.
    Attarian, S.
    Plante-Bordeneuve, V.
    Mezei, M. M.
    Campistol, J. M.
    Buades, J.
    Brannagan, T. H., III
    Kim, B. J.
    Oh, J.
    Parman, Y.
    Sekijima, Y.
    Hawkins, P. N.
    Solomon, S. D.
    Polydefkis, M.
    Dyck, P. J.
    Gandhi, P. J.
    Goyal, S.
    Chen, J.
    Strahs, A. L.
    Nochur, S. V.
    Sweetser, M. T.
    Garg, P. P.
    Vaishnaw, A. K.
    Gollob, J. A.
    Suhr, O. B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 11 - 21
  • [4] Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
    Adams, David
    Tournev, Ivailo L.
    Taylor, Mark S.
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian D.
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Chen, Chongshu
    Badri, Prajakta
    Arum, Seth M.
    Vest, John
    Polydefkis, Michael
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (01): : 18 - 26
  • [5] Adams D, 2021, LANCET NEUROL, V20, P49, DOI 10.1016/S1474-4422(20)30368-9
  • [6] The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines
    Agha, Riaz A.
    Borrelli, Mimi R.
    Farwana, Reem
    Koshy, Kiron
    Fowler, Alexander J.
    Orgill, Dennis P.
    Zhu, Hongyi
    Alsawadi, Abdulrahman
    Noureldin, Ashraf
    Rao, Ashwini
    Enam, Ather
    Thoma, Achilleas
    Bashashati, Mohammad
    Vasudevan, Baskaran
    Beamish, Andrew
    Challacombe, Ben
    De Wilde, Rudy Leon
    Machado-Aranda, David
    Laskin, Daniel
    Muzumdar, Dattatraya
    D'cruz, Anil
    Manning, Todd
    Healy, Donagh
    Pagano, Duilio
    Goel, Prabudh
    Ranganathan, Priya
    Pai, Prathamesh S.
    Raja, Shahzad
    Athe, M. Hammad
    Kadioazlu, Huseyin
    Nixon, Iain
    Mukherjee, Indraneil
    Gomez Riva, Juan
    Raveendran, Kandiah
    Derbyshire, Laura
    Valmasoni, Michele
    Chalkoo, Mushtaq
    Raison, Nicholas
    Muensterer, Oliver
    Bradley, Patrick
    Roberto, Coppola
    Afifi, Raafat
    Rosin, David
    Klappenbach, Roberto
    Wynn, Rolf
    Giordano, Salvatore
    Basu, Somprakas
    Surani, Salim
    Suman, Paritosh
    Thorat, Mangesh
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2018, 60 : 132 - 136
  • [7] Akasaki YL., 2017, J Orthop Res Conf, V35, P1538
  • [8] Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis
    Akasaki, Yukio
    Reixach, Natalia
    Matsuzaki, Tokio
    Alvarez-Garcia, Oscar
    Olmer, Merissa
    Iwamoto, Yukihide
    Buxbaum, Joel N.
    Lotz, Martin K.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2097 - 2107
  • [9] Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, pS452
  • [10] Akinboboye OA, 2015, Orphanet J Rare Dis, V10, pO8